Application of plasmapheresis for Covid-19 patients.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

1. Cost-effectiveness of plasmapheresis and hemoperfusion in COVID-19 survivors: A six-month follow-up analysis after hospital discharge.Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy · 2026
   Article
2. Efficacy of plasmapheresis in neutropenic patients suffering from cytokine storm because of severe COVID-19 infection.Blood research · 2023
   Article
3. Plasma exchange and COVID 19.Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2022
   Article
4. Plasmapherisis in Covid-19 patient under ECMO: A Moroccan case report experience.Annals of medicine and surgery (2012) · 2022
   Article
5. Plasmapheresis: a feasible choice for bullous pemphigoid patients infected with SARS-CoV-2.International journal of dermatology · 2022
   Article
6. Effectiveness of Plasmapheresis Treatment in the Treatment of Patients with COVID-19 Disease.Medical journal of the Islamic Republic of Iran · 2022
   Article
7. Therapeutic Plasma Exchanges in Combination with High-Dose Steroid-Induced Immunosuppression as an Ultima Ratio Therapy in Severe Coronavirus Disease 2019 (COVID-19): A Case-Series Report.Journal of inflammation research · 2022
   Article
8. On Therapeutic Plasma Exchange Against Severe COVID-19-Associated Pneumonia: An Observational Clinical Study.Frontiers in nutrition · 2022
   Article
9. Combination therapy with plasma exchange and glucocorticoid may be effective for severe COVID-19 infection: A retrospective observational study.Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy · 2021
   Observational
10. Understanding the role of therapeutic plasma exchange in COVID-19: preliminary guidance and practices.Vox sanguinis · 2021
    Article
11. The use of therapeutic plasma exchange as adjunctive therapy in the treatment of coronavirus disease 2019: A critical appraisal of the current evidence.Journal of clinical apheresis · 2021
    Review
12. Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy.Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2020
    Review

Corrections and comments

• Commented on by
  Potential limitations of plasmapheresis in treatment of COVID-19 patients: How to overcome them?2021

Authors and funding

3 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as